Intrinsic Value of S&P & Nasdaq Contact Us

Mitesco, Inc. MITI OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Mitesco, Inc. (MITI) , forward earnings yield 5,000.00%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 0.0

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — MITI

Valuation Multiples
P/E (TTM)0.0
Forward P/E0.0
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio16.95
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.42
Forward EPS (Est.)$4.50
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield5,000.00%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-32.92 $0.00 $-403.01K -
2016 $-17.73 $0.00 $-4.88M -
2017 $-2.12 $0.00 $-754K -
2018 $-2.82 $0.00 $-1.42M -
2019 $-4.50 $3.5K $-3.89M -111000%
2020 $-2.22 $0.00 $-2.86M -
2021 $-2.77 $115.99K $-7.92M -6830.5%
2022 $-5.29 $690.53K $-23.24M -3364.9%
2023 $-0.95 $0.00 $-13.33M -
2024 $-0.42 $43.7K $-2.51M -5748.3%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message